subsidiaries for the end of March 31, 2018 which has been reviewed by the Company's auditor, the details are as follows. Q1/2017 Q1/2018 Change Million Baht % Million Baht % Value % Sales Income 2,406.6 81.6
1,221.6 81.8% Share of Profit from Investments in Associates and JVs 491.3 693.3 202.0 41.1% Total Cost 773.7 1,248.6 474.9 61.4% Gross Profit 603.8 1,314.7 710.9 117.7% Net Profit 334.5 972.4 637.9 190.7
Company’s core business. 2) The Company does not have a policy to materially change its core business The Company and its subsidiary, Phuket Fantasea PCL, do not have a policy to change its business operation
clarifies the performance as follows: During the first quarter of 2020, the Company had the total revenue and share of profit and net profit of THB 1,277.8 mm and THB 99.3 mm, respectively. If excluding FX
quarter due to: Share of profit from the Wind Power Plant in the Philippines decreased as a result of the seasonal change that reduced wind speed in the area where the project is located, leading to lower
every segment. There is a positive structural change in PET business in the western markets due to financial stress with two major PET producers operating in these markets. PET margins are recovering back
Company Limited Page 2/2 2. Business Outlook While the Company is gradually regaining its market share back post shutdown from February 2019 to April 2019, the current slowdown continues to pose challenges
www.interpharma.co.th IP_OCS/011/2020 8th June 2020 Subject: Notify the Resolutions of the Board of Directors Meeting, Change of Objectives of Funds Usage, Acquisition of Assets, The Issuance of Debentures and Fix the